Skip to main content

Table 3 Survival analysis of each preoperative factor

From: Analysis of the predictive role and new proposal for surgical strategies based on the modified Tomita and Tokuhashi scoring systems for spinal metastasis

Preoperative factor

No. of patients

Survival period (months)

P value

   

Mean (95% CI)

Median (95% CI)

 

Age

Less than 65

87

19.4 (13.6 - 25.2)

5.8 (4.3 - 7.3)

0.235

65 or more

25

8.6 (5.7 - 11.6)

6.1 (3.8 - 8.5)

Gender

Male

87

16.5 (11.3 - 21.7)

5.8 (4.9 - 6.8)

0.460

Female

25

20.7 (9.9 - 31.4)

8.0 (2.0 - 13.9)

Spinal level

Cervical

21

9.9 (3.6 - 16.2)

4.2 (3.7 - 4.6)

0.373

Thoracic

53

17.7 (11.1 - 24.3)

6.5 (3.4 - 9.7)

Lumbosacral

27

14.9 (8.5 - 21.3)

5.9 (4.9 - 6.8)

Multiple

11

18.3 (2.4 - 34.1)

7.7 (3.4 - 11.9)

Operation type

Type 1

3

35.7 (16.2 - 55.3)

N/A

0.228

Type 2

56

14.1 (9.7 - 18.6)

5.6 (2.2 - 9.0)

Type 3

41

17.6 (9.6 - 25.7)

6.1 (5.3 - 6.9)

Type 4

12

8.8 (2.1 - 15.6)

5.3 (0.2 - 10.3)

Time interval to metastasis*

None

36

24.4 (14.7 - 34.1)

7.8 (1.9 - 13.8)

0.023*

<1 year

20

7.4 (2.9 - 11.9)

5.1 (2.0 - 8.2)

>1 year

56

17.3 (10.7 - 24.0)

5.5 (4.3 - 6.8)

Time interval to operation

Immediate

84

19.7 (13.9 - 25.5)

6.2 (3.8 - 8.7)

0.039

Delayed

28

8.1 (4.5 - 11.7)

5.0 (3.0 - 7.1)

Total

112

17.3 (12.6 - 22.1)

5.8 (5.0 - 6.7)

 
  1. *The interval between the diagnosis of primary malignancy and that of spinal metastasis; the interval between the diagnosis of spinal metastasis and surgery: these intervals were significantly associated with survival according to the log-rank test. N/A, estimation data not available due to the lack of uncensored cases.